#2 - Intuitive Surgical (NASDAQ:ISRG)
Intuitive Surgical (NASDAQ:ISRG) looks like it has recovered from the effects of the pandemic. The medical device company is best known for its da Vinci robotic surgical system. This system is frequently used for the types of surgeries that are frequent with an aging population. And in the company’s most recent earnings report they stated that surgical procedures with the Da Vinci system grew by 28% in 2021. In fact, one out every six surgeries today features some form of robotic assistance.
However, despite the pandemic ISRG stock has been a model of consistent growth for long-term investors. In the five years prior to 2020 (the year of the pandemic), Intuitive Surgical delivered a total return of over 235%. That’s an average of 47% per year. Despite a steep drop at the onset of the pandemic and a second drop at the start of 2022, the stock has climbed by 41% in that time. And analysts give the stock and 18% upside from its current level.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More - Current Price
- $374.14
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 13 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $396.17 (5.9% Upside)
